ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/(alphaS)-alpha-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide hydrochloride
C24H38BClN2O3
448.8 g/mol
Pharmaceutical IntermediateDanger

Phenylalanin-isobutylboronsaure-ester

CAS205393-21-1EC813-658-6
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a pharmaceutical intermediate used in the manufacturing of bortezomib, a compound for research and supply chain applications. It is a salt-like, stereochemically defined molecule containing an amide and an aromatic ring.

pharmaceutical intermediate for bortezomib manufacturingresearch compound for proteasome inhibitor studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Phenylalanin-isobutylboronsaure-ester?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ApplicationSame Use

Isobutaneboronic acid

CAS84110-40-7

pharmaceutical intermediate

ReferenceSame Category

1-N-Boc-2-(hydroxymethyl)piperazine

CAS205434-75-9

pharmaceutical intermediate

ReferenceSame Category

4-Chloro-6-methoxyquinolin-7-ol

CAS205448-31-3

pharmaceutical intermediate

ReferenceSame Category

4-Chloro-7-methoxyquinoline-6-carboxylic acid methyl ester

CAS205448-66-4

pharmaceutical intermediate

ReferenceSame Category

D-Pyroglutamic acid tert-butyl ester

CAS205524-46-5

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Corrosive
Corrosive
Toxic
Toxic
Harmful
Harmful
Danger
H301Toxic if swallowed
H315Causes skin irritation
H317May cause an allergic skin reaction
H318Causes serious eye damage
Identifiers
IUPAC Name

(2S)-2-amino-N-[(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]butyl]-3-phenylpropanamide;hydrochloride

InChIKey

BYRWVECJDRGBAH-UMPWXGAWSA-N

SMILES

B1(O[C@@H]2C[C@@H]3C[C@H]([C@@]2(O1)C)C3(C)C)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=CC=C4)N.Cl

Synonyms (8)
  • Bortezomib intermediates II

Sourcing Phenylalanin-isobutylboronsaure-ester?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→